Evidence map›Paper›PMID 28411336›Full record

ReviewEuropean journal of nuclear medicine and molecular imaging2017

FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas.

Sally F Barrington, Regine Kluge

Open access · hybridAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in European journal of nuclear medicine and molecular imaging, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 130 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
130citing papers in PubMed, 4 pooled it
21.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

130 citing papers in PubMed, 4 syntheses or guidelines pooled it, 277 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Could treatment modification based on early response assessment improve results in DLBCL?Hematology. American Society of Hematology. Education Program · 2025
    Review
  18. Characteristics of pulmonary lymphoma on baselineQuantitative imaging in medicine and surgery · 2025
    Article
  19. Nuclear medicine and molecular imaging · 2025
    Article
  20. Review

70 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Sally F BarringtonPET Imaging Centre, King's College London and Guy's, King's Health Partners, St. Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK. sally.barrington@kcl.ac.uk.ORCID http://orcid.org/0000-0002-2516-5288
Regine KlugeDepartment of Nuclear Medicine, University Hospital of Leipzig, 0410, Leipzig, Germany.
St Thomas' Hospital · GBUniversity Hospital Leipzig · DE

Funding

Cancer Research UK 16463Department of Health RP-2016-07-001
6 · The paper itself

Abstract

PET using

Indexed as

Fluorodeoxyglucose F18Hodgkin DiseaseHumansLymphoma, Non-HodgkinPositron-Emission TomographyTreatment OutcomeFluorodeoxyglucose F18DiagnosisLymphomaPositron emission tomographyPrecision medicineTherapy

Identifiers

PMID28411336
PMCPMC5541086
OpenAlexW2606364858

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.